We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Fevertree Drinks Plc | LSE:FEVR | London | Ordinary Share | GB00BRJ9BJ26 | ORD 0.25P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
13.00 | 1.14% | 1,157.00 | 1,153.00 | 1,157.00 | 1,168.00 | 1,130.00 | 1,151.00 | 156,155 | 16:29:50 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Wine & Alcoholic Bev-whsl | 364.4M | 15.4M | 0.1320 | 87.65 | 1.35B |
Date | Subject | Author | Discuss |
---|---|---|---|
02/11/2017 12:16 | Feels like a kangaroo tail forming. If tu good next week this should be the case. I always look at movement like this with scepticism. The mms may well be looking at shaking out weak holders. Look at iqe from 160 to 105 now close to 160 again. Fevertree has had a gentle fall until recently. The large director sales may well have satisfied the institutions, so a gradual fall could have been foreseen, but weak holders need to be shaken out, for a strong move forward. | jch18 | |
02/11/2017 11:30 | Gap closed. Bounced off the 200 day sma. Surely all good no? Just need a nice hammer to accompany the volume... | allstar4eva | |
02/11/2017 11:16 | Not sure why they'd do a placing when they have £33m in the bank and only £6m debt | villarich | |
02/11/2017 11:15 | This maybe of Interest to some on the Tonic battle ahead. I've noticed in my local Booker C&C you now get a case of Schweppes 1783 Tonic when you buy 4 bottles of premium Gin. For the past 18 months the same deal has run with Fevertree as the free tonic. | jonnyfaz | |
02/11/2017 10:14 | This from earlier: 2 November RBC Capital Markets cut its price target to 2000p (from 2400p) RBC CAPITAL CUTS FEVERTREE DRINKS TO 'SECTOR PERFORM' ('OUTPERFORM') | martywidget | |
02/11/2017 10:09 | Lol indeed. It's ok he'll be scouring the old broker notes again to reassure himself that he's done the right thing. This is one big tree shake - but as far as we know there is no bad news. One would assume that there would be a shed load of promotions if sales were poor. I looked at Schweppes the other day on MySupermarket - on offer in pretty much every major grocer. Also if news had leaked then I would have thought there would be massive selling. This looks like a prolonged 'attack' on the share price Any thoughts? | juzzer100 | |
02/11/2017 10:06 | Wetdream - he's busy searching the internet for news articles from July. | villarich | |
02/11/2017 10:03 | Lol @ wetdream | sogoesit | |
02/11/2017 09:54 | I see ShareScope/SharePad very recently extended their equity universe to include 2500 odd European stocks which is a boon, although around 80% appear to trade very lightly, of which the majority are totally illiquid. Never realised how good we had it on the LSE. My reason for mentioning this is I am looking for an affordable news service that offers some search capability ... if you know of one please get in touch. For the record, I am arms length to Ionic (holding company of SS & SP). Thanks | staverly | |
02/11/2017 09:51 | Hope christh's ok. | wetdream | |
02/11/2017 09:49 | I see ShareScope/SharePad very recently extended their equity universe to include 2500 odd European stocks which is a boon, although around 80% appear to trade very lightly, of which the majority are totally illiquid. Never realised how good we had it on the LSE. My reason for mentioning this is I am looking for an affordable news service that offers some search capability ... if you know of one please get in touch. For the record, I am arms length to Ionic (holding company of SS & SP). Thanks | staverly | |
02/11/2017 09:44 | Another occasion to buy one of the best stocks for a very cheap price. | orissander | |
02/11/2017 09:30 | Thankfully IQE seems to be inversely related to FEVR today so the portfolio isn't getting hit. Who knew wafers and tonic waters were interrelated? | villarich | |
02/11/2017 09:29 | Damn. Love fevertree but thought overvalued short term and nearly went short at 23. Wish I had. Sitting on my hands now though . Dangerous game to play. Still a great company | 1savvyinvestor | |
02/11/2017 09:28 | Heading for the gap fill at just below 18 and then who knows. | elsa7878 | |
02/11/2017 09:25 | Strong early volume. Skinny1 Nov '17 - 15:48 - 1160 of 1189 0 1 Edit Gap to fill from late July? | skinny | |
02/11/2017 09:15 | Interesting comment from LSE: ....'It's easy to take a UK-centric view and see the recent competition as a concern but don't forget that the International growth continues unabated. Schweppes can redesign their bottles but the ingredients remain the same and this was always the key USP for Fever Tree, not the packaging. Also, remember that different people own Schweppes in different markets, so it can't make a united effort against FEVR globally.' | wetdream | |
02/11/2017 09:13 | I've taken some chips off the table this morning, only because I need the cash for a personal tax bill at the end of January. The rest of my shares are in my SIPP and won't be going anywhere. May also top up but only if there are moves upwards after news. I'm not second guessing results anymore after getting burned by BOO. | villarich | |
02/11/2017 09:09 | Well, the gap-up was a re-rated view with a lot more liquidity coming into the market. That exuberance may have dried up in which case, yes, it may get filled imv. Is the stock worth 60+ times EPS looking forward? If not, or there are doubts, then it will definitely fall. Views only. I hold. Will add at £18'ish if it does fall before expected news next week. | sogoesit | |
02/11/2017 09:07 | Starting to look that way but in 2 trading sessions ? | panic investor | |
02/11/2017 09:04 | What's the view? Does the July gap up (from £18) have to be filled? | wetdream |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions